|Articles|September 1, 2011
- BioPharm International-09-01-2011
- Volume 24
- Issue 9
BioPharm International, September 2011 Issue (PDF)
Structures and Manufacturing Support
Advertisement
Articles in this issue
over 14 years ago
Manufacturers and FDA Gear Up for User-Fee Actionover 14 years ago
The Future of Downstream Processingover 14 years ago
Following Our Own Instructionsover 14 years ago
Technologies for Downstream Processingover 14 years ago
Retrospection and Introspection at FDAover 14 years ago
The EU Debt Crisis and CMOsover 14 years ago
Advocating for Biosimilar Approval Standards Under BPCINewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
2
Implementing Automation and Flexible Design for Allogeneic Manufacturing
3
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
4
Emerging siRNA Platform Offers New Metabolic Disorder Therapies
5
